Related Experiment Video
Updated: Jun 17, 2026
Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
Elevated levels of HMGB1 in cancerous and inflammatory effusions
Nina Winter1, Anke Meyer, Andreas Richter
1Centre for Human Genetics, University of Bremen, Leobener Str. ZHG, 28359 Bremen, Germany.
Background:
Recently, it has become obvious that the HMGB1 protein can act as a proinflammatory and proangiogenic mediator when actively secreted by macrophages or passively released from necrotic cells playing an important role in the pathogenesis of several diseases including cancer.
Materials And Methods:
The absolute and relative amount of HMGB1 was measured with an ELISA in different effusion types.
Results:
The amount of HMGB1 protein in the samples differed between 0.0004% and 0.0025% of the total sample protein. The mean values of transudates were significantly (p<0.001) lower than the mean values of exudates.
Conclusion:
HMGB1, a so-called danger signalling protein, was found to be highly expressed in human pleural and peritoneal effusions due to cancer and inflammation. Compared to transudates the average level of HMGB1 was significantly higher in exudates. These results underline the characteristics of HMGB1 as a possible target for treatment in advanced cancer as well.
